Fiveleaf gynostemma herblipid-lowering tea

Abstract

The invention discloses fiveleaf gynostemma herb lipid-lowering tea. A formula of the fiveleaf gynostemma herb lipid-lowering tea comprises the following components in parts by mass of 4 to 6 parts of raw fructus crataegi, 3 to 6 parts of fiveleaf gynostemma herb, 2 to 4 parts of semen cassiae torae, 0.5 to 1.5 parts of ramulus uncariae cum uncis, 0.5 to 1.5 parts of folium nelumbinis, 0.5 to 1.5 parts of pericarpium citri reticulatae and 0.5 to 1.5 parts of tea leaves. The fiveleaf gynostemma herb has the effects of remarkably reducing cholesterol, triglyceride and low-density lipoprotein, increasing high-density lipoprotein, protecting blood vessel inner wall cells, preventing lipid from depositing on blood vessel walls and resisting arteriosclerosis; and the raw fructus crataegi, the fiveleaf gynostemma herb, the semen cassiae torae, the ramulus uncariae cum uncis, the folium nelumbinis, the pericarpium citri reticulatae and the tea leaves are matched according to the component range, so that the tea is drunk by patients suffering from hyperlipidemia of different degrees, and has the characteristics of being quick in effect taking and good in treatment effect.

Description

technical field [0001] The invention relates to the technical field of health-care tea, in particular to Gynostemma pentaphyllum for reducing fat. Background technique [0002] In recent years, the blood lipid level and changing trend of the Chinese population have attracted the attention of scholars at home and abroad. According to statistics, the prevalence of hyperlipidemia is increasing year by year. About 10%-20% of adults have elevated serum total cholesterol or triglycerides, and even about 10% of children have elevated blood lipids. This is closely related to the continuous improvement of the living standards of our people and the changes in dietary structure and habits. In addition, long-term hyperlipidemia can also cause hypertension, cerebral hemorrhage, cerebral embolism, liver cirrhosis, fatty liver, renal failure, diabetes and other diseases. [0003] At present, the treatment of hyperlipidemia mainly focuses on improving various abnormal blood lipid componen...

AI Technical Summary

Problems solved by technology

The lipid-lowering drugs used in the above-mentioned treatment of hyperlipidemia all belong to the western medicine class, and while exerting a relatively good effect, a large number of adverse reactions (such as nausea, liver dysfunction, and rhabdomyolysis, etc.)